{"id":"W2971487735","doi":"10.1016/s1474-4422(19)30238-8","title":"Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital; McGill University; University of Toronto; NeuroRx Research (Canada)","funders":"Javna Agencija za Raziskovalno Dejavnost RS; Celgene","keywords":"Medicine; Internal medicine; Population; Clinical endpoint; Placebo; Multiple sclerosis; Clinical trial; Physical therapy; Pathology; Immunology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002554465,0.001918566,0.003996495,0.0004277322,0.0006139468,0.001372202,0.001012254,0.002534951,0.005118782],"category_scores_gemma":[0.002387082,0.0007037541,0.003129286,0.0004983627,0.0015415,0.001510772,0.0006222462,0.003819585,0.001026932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009743465,"about_ca_system_score_gemma":0.001071238,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001251681,"about_ca_topic_score_gemma":0.001968854,"domain_scores_codex":[0.9988452,0.0006895239,0.00006974864,0.0001553105,0.00006931398,0.000170903],"domain_scores_gemma":[0.9985935,0.0004560277,0.0003866985,0.0001122446,0.00007075821,0.0003808961],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9906413,0.001232726,0.0003031336,0.0002967006,0.0005856506,0.00001988238,0.00003982638,0.0001176982,0.000929895,0.00003520456,0.0002272454,0.005570866],"study_design_scores_gemma":[0.959164,0.03788142,0.001832601,0.00003109898,0.0004084345,0.00002555038,0.0000259285,0.0001451011,0.0001561708,0.00009378514,0.0002220727,0.00001380158],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902824,0.006153507,0.0002882635,0.0005803583,0.0003321511,0.0008878555,0.0005501861,0.00006028643,0.0008649413],"genre_scores_gemma":[0.9920203,0.002319891,0.000801233,0.0008260108,0.0003438597,0.001373733,0.0006645553,0.00002398085,0.001626374],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005118782,"threshold_uncertainty_score":0.01712406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1008831938011834,"score_gpt":0.3344472093053279,"score_spread":0.2335640155041445,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}